Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 91

    1.

    Evaluation of a patient care delivery model: patient outcomes in acute cardiac care.

    Meyer RM, Wang S, Li X, Thomson D, O'Brien-Pallas L.

    J Nurs Scholarsh. 2009;41(4):399-410.PMID: 19941586 [PubMed - in process]

    2.

    Generalizing the Results of Cancer Clinical Trials.

    Meyer RM.

    J Clin Oncol. 2009 Nov 23. [Epub ahead of print] No abstract available. PMID: 19933900 [PubMed - as supplied by publisher]

    3.

    I-Tositumomab in lymphoma.

    Cheung MC, Maceachern JA, Haynes AE, Meyer RM, Imrie K; the Members of the Hematology Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care.

    Curr Oncol. 2009 Sep;16(5):32-47.PMID: 19862360 [PubMed - as supplied by publisher]Related articlesFree article

    4.

    Improving cancer outcomes through international collaboration in academic cancer treatment trials.

    Trimble EL, Abrams JS, Meyer RM, Calvo F, Cazap E, Deye J, Eisenhauer E, Fitzgerald TJ, Lacombe D, Parmar M, Seibel N, Shankar L, Swart AM, Therasse P, Vikram B, von Frenckell R, Friedlander M, Fujiwara K, Kaplan RS, Meunier F.

    J Clin Oncol. 2009 Oct 20;27(30):5109-14. Epub 2009 Aug 31.PMID: 19720905 [PubMed - in process]Related articles

    5.

    Presentation of nonfinal results of randomized controlled trials at major oncology meetings.

    Booth CM, Le Maître A, Ding K, Farn K, Fralick M, Phillips C, Cescon DW, Meyer RM.

    J Clin Oncol. 2009 Aug 20;27(24):3938-44. Epub 2009 Jul 20.PMID: 19620490 [PubMed - indexed for MEDLINE]Related articles

    6.

    A century of research in nursing human resources.

    O'Brien-Pallas L, Meyer RM.

    Can Nurse. 2008 Nov;104(9):29-30. No abstract available. PMID: 19105321 [PubMed - indexed for MEDLINE]Related articles

    7.

    The Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group.

    Courneya KS, Booth CM, Gill S, O'Brien P, Vardy J, Friedenreich CM, Au HJ, Brundage MD, Tu D, Dhillon H, Meyer RM.

    Curr Oncol. 2008 Dec;15(6):271-8.PMID: 19079628 [PubMed - in process]Related articlesFree article

    8.

    Genotyping North American animal Mycobacterium bovis isolates using multilocus variable number tandem repeat analysis.

    Martinez LR, Harris B, Black WC 4th, Meyer RM, Brennan PJ, Vissa VD, Jones RL.

    J Vet Diagn Invest. 2008 Nov;20(6):707-15.PMID: 18987219 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Span of management: concept analysis.

    Meyer RM.

    J Adv Nurs. 2008 Jul;63(1):104-12. Review.PMID: 18598254 [PubMed - indexed for MEDLINE]Related articles

    10.

    Evaluation of a four year intervention to reduce musculoskeletal hazards among berry growers.

    Chapman LJ, Newenhouse AC, Pereira KM, Karsh BT, Meyer RM, Brunette CM, Ehlers JJ.

    J Safety Res. 2008;39(2):215-24. Epub 2008 Mar 20.PMID: 18454973 [PubMed - indexed for MEDLINE]Related articles

    11.

    A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma.

    Hicks LK, Haynes AE, Reece DE, Walker IR, Herst JA, Meyer RM, Imrie K; Hematology Disease Site Group of the Cancer Care Ontario Program in Evidence-based Care.

    Cancer Treat Rev. 2008 Aug;34(5):442-52. Epub 2008 Apr 1. Review.PMID: 18381234 [PubMed - indexed for MEDLINE]Related articles

    12.

    Patterns of disease progression and outcomes in a randomized trial testing ABVD alone for patients with limited-stage Hodgkin lymphoma.

    Macdonald DA, Ding K, Gospodarowicz MK, Wells WA, Pearcey RG, Connors JM, Winter JN, Horning SJ, Djurfeldt MS, Shepherd LE, Meyer RM.

    Ann Oncol. 2007 Oct;18(10):1680-4. Epub 2007 Sep 10.PMID: 17846017 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Phase II testing of sunitinib: the National Cancer Institute of Canada Clinical Trials Group IND Program Trials IND.182-185.

    Buckstein R, Meyer RM, Seymour L, Biagi J, Mackay H, Laurie S, Eisenhauer E.

    Curr Oncol. 2007 Aug;14(4):154-61.PMID: 17710208 [PubMed - in process]Related articlesFree article

    15.

    Development of adapted RECIST criteria to assess response in lymphoma and their comparison to the International Workshop Criteria.

    Assouline S, Meyer RM, Infante-Rivard C, Connors JM, Belch A, Crump M, Kouroukis CT, Eisenhauer E.

    Leuk Lymphoma. 2007 Mar;48(3):513-20.PMID: 17454591 [PubMed - indexed for MEDLINE]Related articles

    16.

    Rituximab in lymphoma: a systematic review and consensus practice guideline from Cancer Care Ontario.

    Cheung MC, Haynes AE, Meyer RM, Stevens A, Imrie KR; Members of the Hematology, Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care.

    Cancer Treat Rev. 2007 Apr;33(2):161-76. Epub 2007 Jan 22. Review.PMID: 17240533 [PubMed - indexed for MEDLINE]Related articles

    17.

    A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7.

    Shustik C, Belch A, Robinson S, Rubin SH, Dolan SP, Kovacs MJ, Grewal KS, Walde D, Barr R, Wilson J, Gill K, Vickars L, Rudinskas L, Sicheri DA, Wilson K, Djurfeldt M, Shepherd LE, Ding K, Meyer RM.

    Br J Haematol. 2007 Jan;136(2):203-11.PMID: 17233817 [PubMed - indexed for MEDLINE]Related articles

    18.

    Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura.

    Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, Fraser GA, Lim W, Kelton JG.

    Ann Intern Med. 2007 Jan 2;146(1):25-33. Review.PMID: 17200219 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Climate change hearings and policy issues.

    Meyer RM.

    Science. 2006 Dec 15;314(5806):1681-2. No abstract available. PMID: 17170274 [PubMed]Related articles

    20.

    The management of patients with limited-stage classical Hodgkin lymphoma.

    Gospodarowicz MK, Meyer RM.

    Hematology Am Soc Hematol Educ Program. 2006:253-8. Review.PMID: 17124069 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Yttrium 90 ibritumomab tiuxetan in lymphoma.

    Cheung MC, Haynes AE, Stevens A, Meyer RM, Imrie K; Members of the Hematology Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care.

    Leuk Lymphoma. 2006 Jun;47(6):967-77. Review. Erratum in: Leuk Lymphoma. 2006 Aug;47(8):1719-20. PMID: 16840185 [PubMed - indexed for MEDLINE]Related articles

    22.

    A phase II study of ZD6474 (Zactima, a selective inhibitor of VEGFR and EGFR tyrosine kinase in patients with relapsed multiple myeloma--NCIC CTG IND.145.

    Kovacs MJ, Reece DE, Marcellus D, Meyer RM, Mathews S, Dong RP, Eisenhauer E.

    Invest New Drugs. 2006 Nov;24(6):529-35.PMID: 16791411 [PubMed - indexed for MEDLINE]Related articles

    23.

    Abattoir surveillance: the U.S. experience.

    Kaneene JB, Miller R, Meyer RM.

    Vet Microbiol. 2006 Feb 25;112(2-4):273-82. Epub 2005 Dec 2. Review.PMID: 16326037 [PubMed - indexed for MEDLINE]Related articles

    24.

    Is there convincing evidence for the use of chemotherapy alone in patients with limited stage Hodgkin's lymphoma?

    Meyer RM.

    Eur J Haematol Suppl. 2005 Jul;(66):115-20. Review.PMID: 16007879 [PubMed - indexed for MEDLINE]Related articles

    25.

    Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.

    Meyer RM, Gospodarowicz MK, Connors JM, Pearcey RG, Bezjak A, Wells WA, Burns BF, Winter JN, Horning SJ, Dar AR, Djurfeldt MS, Ding K, Shepherd LE; National Cancer Institute of Canada Clinical Trials Group; Eastern Cooperative Oncology Group.

    J Clin Oncol. 2005 Jul 20;23(21):4634-42. Epub 2005 Apr 18.PMID: 15837968 [PubMed - indexed for MEDLINE]Related articles

    26.

    Autologous peripheral blood progenitor cells are a potential source of parvovirus B19 infection.

    Arnold DM, Neame PB, Meyer RM, Soamboonsrup P, Luinstra KE, O'Hoski P, Garner J, Foley R.

    Transfusion. 2005 Mar;45(3):394-8.PMID: 15752157 [PubMed - indexed for MEDLINE]Related articles

    27.

    Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant.

    Stewart AK, Chen CI, Howson-Jan K, White D, Roy J, Kovacs MJ, Shustik C, Sadura A, Shepherd L, Ding K, Meyer RM, Belch AR.

    Clin Cancer Res. 2004 Dec 15;10(24):8170-6.PMID: 15623591 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Hodgkin's lymphoma: evolving concepts with implications for practice.

    Meyer RM, Ambinder RF, Stroobants S.

    Hematology Am Soc Hematol Educ Program. 2004:184-202. Review.PMID: 15561683 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen.

    Klasa RJ, Meyer RM, Shustik C, Sawka CA, Smith A, Guévin R, Maksymiuk A, Rubinger M, Samosh M, Laplante S, Grenier JF.

    J Clin Oncol. 2002 Dec 15;20(24):4649-54.PMID: 12488409 [PubMed - indexed for MEDLINE]Related articles

    30.

    A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets.

    Heddle NM, Blajchman MA, Meyer RM, Lipton JH, Walker IR, Sher GD, Constantini LA, Patterson B, Roberts RS, Thorpe KE, Levine MN.

    Transfusion. 2002 May;42(5):556-66.PMID: 12084163 [PubMed - indexed for MEDLINE]Related articles

    31.

    The role of high-dose chemotherapy and stem-cell transplantation in patients with multiple myeloma: a practice guideline of the Cancer Care Ontario Practice Guidelines Initiative.

    Imrie K, Esmail R, Meyer RM; Members of the Hematology Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative.

    Ann Intern Med. 2002 Apr 16;136(8):619-29.PMID: 11955031 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Utilization-focused evaluation: evaluating the effectiveness of a hospital nursing orientation program.

    Meyer RM, Meyer MC.

    J Nurses Staff Dev. 2000 Sep-Oct;16(5):202-6; quiz 207-8.PMID: 11913016 [PubMed - indexed for MEDLINE]Related articles

    33.

    Chemotherapy for older patients with newly diagnosed, advanced-stage, aggressive-histology non-Hodgkin lymphoma: a systematic review.

    Kouroukis CT, Browman GP, Esmail R, Meyer RM.

    Ann Intern Med. 2002 Jan 15;136(2):144-52. Review.PMID: 11790067 [PubMed - indexed for MEDLINE]Related articles

    34.

    Treatment strategies in elderly patients with aggressive histology lymphoma.

    Kouroukis CT, Meyer RM.

    Ann Hematol. 2001;80 Suppl 3:B86-8. Review. No abstract available. PMID: 11757717 [PubMed - indexed for MEDLINE]Related articles

    35.

    Using adult learning concepts to assist patients in completing advance directives.

    Meyer RM.

    J Contin Educ Nurs. 2000 Jul-Aug;31(4):174-8. Review.PMID: 11261162 [PubMed - indexed for MEDLINE]Related articles

    36.

    A comparison of elderly patients with aggressive histology lymphoma who were entered or not entered on to a randomized phase II trial.

    Chen CI, Skingley P, Meyer RM.

    Leuk Lymphoma. 2000 Jul;38(3-4):327-34.PMID: 10830739 [PubMed - indexed for MEDLINE]Related articles

    37.

    A phase I trial of standard and cyclophosphamide dose-escalated CHOP with granulocyte colony stimulating factor in elderly patients with non-Hodgkin's lymphoma.

    Meyer RM, Gyger M, Langley R, Lespérance B, Caplan SN.

    Leuk Lymphoma. 1998 Aug;30(5-6):591-600.PMID: 9711921 [PubMed - indexed for MEDLINE]Related articles

    38.

    Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.

    Connors JM, Klimo P, Adams G, Burns BF, Cooper I, Meyer RM, O'Reilly SE, Pater J, Quirt I, Sadura A, Shustik C, Skillings J, Sutcliffe S, Verma S, Yoshida S, Zee B.

    J Clin Oncol. 1997 Apr;15(4):1638-45. Erratum in: J Clin Oncol 1997 Jul;15(7):2762. PMID: 9193364 [PubMed - indexed for MEDLINE]Related articles

    39.

    Augustine guide.

    Meyer RM.

    Can J Anaesth. 1996 Jun;43(6):642-3. No abstract available. PMID: 8773878 [PubMed - indexed for MEDLINE]Related articles

    40.

    CD2+, CD3-, CD56/NCAM+ malignant lymphoma with TCR beta gene rearrangement: a case report.

    Savilo E, Meyer RM, Soamboonsrup P, Sunisloe L, Frank GL, Simon GT, Neame PB.

    Am J Hematol. 1995 Nov;50(3):209-14.PMID: 7485082 [PubMed - indexed for MEDLINE]Related articles

    41.

    Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma.

    Meyer RM, Browman GP, Samosh ML, Benger AM, Bryant-Lukosius D, Wilson WE, Frank GL, Leber BF, Sternbach MS, Foster GA, et al.

    J Clin Oncol. 1995 Sep;13(9):2386-93.PMID: 7666098 [PubMed - indexed for MEDLINE]Related articles

    42.

    Implications of using a prognostic index to select therapy for patients with aggressive histology lymphoma.

    Meyer RM, Browman GP.

    Can J Oncol. 1995 Mar;5(1):344-54.PMID: 8853477 [PubMed - indexed for MEDLINE]Related articles

    43.

    Proper interpretation of increased ventilatory requirements.

    Meyer RM.

    Anesth Analg. 1994 Dec;79(6):1209-10. No abstract available. PMID: 7978455 [PubMed - indexed for MEDLINE]Related articles

    44.

    Relation between platinum-DNA adducts and complete remission in adult acute nonlymphocytic leukemia.

    Armstrong SG, Browman GP, Benger AM, Meyer RM, McKay KL, Singh G.

    Leuk Res. 1994 Sep;18(9):659-64.PMID: 7934140 [PubMed - indexed for MEDLINE]Related articles

    45.

    Costs of inhaled anesthetics.

    Meyer RM.

    Anesthesiology. 1994 Jun;80(6):1406; author reply 1407-8. No abstract available. PMID: 8010492 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Escalated as compared with standard doses of doxorubicin in BACOP therapy for patients with non-Hodgkin's lymphoma.

    Meyer RM, Quirt IC, Skillings JR, Cripps MC, Bramwell VH, Weinerman BH, Gospodarowicz MK, Burns BF, Sargeant AM, Shepherd LE, et al.

    N Engl J Med. 1993 Dec 9;329(24):1770-6.PMID: 7694148 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Liquid full nitrous oxide cylinders.

    Meyer RM, Ferderbar PJ.

    Anesthesiology. 1993 Mar;78(3):584-6. No abstract available. PMID: 8457058 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Cable-testing device fails to indicate that hypertension is artifactual.

    Meyer RM, Kimovec MA, Hefner GG.

    J Clin Monit. 1993 Jan;9(1):54-9.PMID: 8463806 [PubMed - indexed for MEDLINE]Related articles

    49.

    A pilot study of carboplatin augmentation therapy for patients with poor risk acute non-lymphocytic leukemia.

    Benger AM, Browman GP, Walker IR, Meyer RM, Wilson WE, McBride JA.

    Leuk Res. 1992;16(2):159-63.PMID: 1545569 [PubMed - indexed for MEDLINE]Related articles

    50.

    The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma.

    Meyer RM, Hryniuk WM, Goodyear MD.

    J Clin Oncol. 1991 Feb;9(2):339-47.PMID: 1824863 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...